Costs of cannabis testing compliance: Assessing mandatory testing in the California cannabis market. by Valdes-Donoso, Pablo et al.
UC Davis
UC Davis Previously Published Works
Title
Costs of cannabis testing compliance: Assessing mandatory testing in the California 
cannabis market.
Permalink
https://escholarship.org/uc/item/1rx4w1fd
Journal
PloS one, 15(4)
ISSN
1932-6203
Authors
Valdes-Donoso, Pablo
Sumner, Daniel A
Goldstein, Robin
Publication Date
2020
DOI
10.1371/journal.pone.0232041
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
RESEARCH ARTICLE
Costs of cannabis testing compliance:
Assessing mandatory testing in the California
cannabis market
Pablo Valdes-DonosoID1*, Daniel A. Sumner1,2, Robin Goldstein1
1 Agricultural Issues Center, University of California, Davis, California, United States of America,
2 Department of Agriculture and Resource Economics, University of California Davis, Davis, California,
United States of America
* pvaldesdonoso@ucdavis.edu
Abstract
Most U.S. states that have regulated and taxed cannabis have imposed some form of man-
datory safety testing requirements. In California, the country’s largest and oldest legal can-
nabis market, mandatory testing was first enforced by state regulators in July 2018, and
additional mandatory tests were introduced at the end of 2018. All cannabis must be tested
and labeled as certified by a state-licensed cannabis testing laboratory before it can be
legally marketed in California. Every batch that is sold by licensed retailers must be tested
for more than 100 contaminants, including 66 pesticides with tolerance levels lower than the
levels allowable for any other agricultural product in California. This paper estimates the
costs of compliance with mandatory cannabis testing laws and regulations, using Califor-
nia’s testing regime as a case study. We use state government data, data collected from
testing laboratories, and data collected from lab equipment suppliers to run a set of Monte
Carlo simulations and estimate the cost per pound of compliance with California’s new can-
nabis testing regulations. We find that cost per pound is highly sensitive to average batch
size and testing failure rates. We present results under a variety of different assumptions
about batch size and failure rates. We also find that under realistic assumptions, the loss of
cannabis that must be destroyed if a batch fails testing accounts for a larger share of total
testing costs than does the cost of the lab tests. Using our best estimates of average batch
size (8 pounds) and failure rate (4%) in the 2019 California market, we estimate testing cost
at $136 per pound of dried cannabis flower, or about 10 percent of the reported average
wholesale price of legal cannabis in the state. Our findings explain effects of the testing stan-
dards on the cost of supplying legal licensed cannabis, in California, other U.S. states, and
foreign jurisdictions with similar testing regimes.
Introduction
U.S. state markets for cannabis are evolving rapidly. As of mid-2019, 32 of 50 states had some
form of legal medicinal cannabis system in place, and since 2012, 11 of those states had legal-
ized and regulated adult-use cannabis [1].
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California was the first U.S. state to decriminalize the sale of medicinal cannabis, with the
1996 passage of the Compassionate Use Act (Proposition 215). In 2003, a California state legis-
lative act, Senate Bill 420, set out more specific rules for the operation of medicinal cannabis
collectives and cooperatives. For the following 15 years, regulations on the cultivation,
manufacturing, and sale of cannabis in California were largely limited to a wide variety of local
ordinances, with little intervention from the state government.
In November 2016, California voters legalized adult-use cannabis by approving Proposition
64 (the Adult Use of Marijuana Act, or AUMA). Subsequently, the Medicinal and Adult-Use
Cannabis Regulation and Safety Act of 2017 (MAUCRSA) created a unified framework for the
state licensing of cannabis businesses and the taxation and regulation of adult-use and medici-
nal cannabis. MAUCRSA regulations went into effect on January 1, 2018 [2].
Safety regulations generally add costs to production. One of the most costly components of
California’s new system of cannabis regulation is the mandatory testing of all legal cannabis
for more than 100 contaminants, including pesticides and heavy metals. This paper is the first
to comprehensively examine the economic challenges of cannabis testing and estimate the cost
of testing compliance per pound of cannabis marketed in a legal and licensed cannabis market.
In a previous article [2], we provide a brief introduction to testing costs to which this paper
supplies needed rigor.
We review and compare the allowable tolerance levels for contaminants in cannabis with
allowable levels in other crops from California, and review rejection rates in California since
mandatory testing began in 2018. We compare these with rejection rates in other U.S. states
where medical and recreational use of cannabis are permitted. We use primary data from Cali-
fornia’s major cannabis testing laboratories, several cannabis testing equipment manufactur-
ers, Bureau of Cannabis Control license data including geographical location information, and
data from Cannabis Benchmarks on average wholesale batch sizes to estimate the testing cost
per pound of cannabis legally marketed in California.
Background
At the U.S. federal level, cannabis is still classified as a Schedule I illegal narcotic, and its pos-
session, sale, and even testing are serious criminal offenses under federal law [3,4]. Even can-
nabis businesses that are fully compliant with state regulations thus face legal risks,
uncertainties, and obstacles to doing business such as a lack of access to mainstream banks [5].
In recent years, however, the conflict of state and federal laws has generally been mediated via
a series of informal, non-binding agreements, letters, and memos of understanding between
the U.S. Department of Justice and states. These understandings have enabled cannabis busi-
nesses to focus more on complying with state and local laws than on hiding from federal
prosecutors.
All of the U.S. states that have legalized, taxed, and regulated recreational cannabis, and
most states that have legalized and regulated medicinal cannabis, require testing for some con-
taminants (e.g. fungus, mold, bacteria, and mycotoxins) and testing and labeling of potency
(as measured by concentrations of cannabinoids such as the phytocannabinoid tetrahydrocan-
nabinol, or THC, and cannabidiol, or CBD). Colorado and Washington were the first states to
vote to legalize and regulate adult-use cannabis, both in 2012. Colorado first introduced the
enforcement of potency and homogeneity tests for retail cannabis products in 2014. Residual
solvents and microbial contaminants were added to the testing requirements in 2015, and
heavy metals and pesticide residues as of mid-2018 [6–8]. Washington State mandates that
licensed testing laboratories must also perform potency tests, moisture analysis, foreign matter,
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microbial and mycotoxin screenings, and (for extracted cannabis, e.g. cannabis oil) screenings
for residual solvents [9].
Some states, including California and Colorado but not Washington, also require more
sophisticated and costly wet-lab tests for pesticides and heavy metals. Per MAUCRSA, the Cal-
ifornia Department of Pesticide Regulation (DPR) established maximum allowable thresholds
for 66 different pesticides, including zero tolerance for trace amounts of 21 pesticides and low
allowable trace amounts of 45 other pesticides. MAUCRSA also established thresholds for 22
residual solvents plus a variety of heavy metals and other contaminants. The Bureau of Canna-
bis Control (BCC) was put in charge of licensing and regulating testing labs and enforcing the
testing standards.
In the 2016 marketplace, prior to the passage of Proposition 64—which was unregulated at
the state level and partially regulated (medicinally) at the local level—total California cannabis
production was estimated at approximately 13.5 million pounds of raw flower, with roughly
80% of this production illegally shipped out of the state [10]. These out-of-state shipments may
explain why California accounted for 70% of nationwide cannabis confiscations in 2016 [11].
Rough estimates suggest that only about one-quarter of California’s in-state cannabis con-
sumption, or less than 5% of total cannabis production, went to the legal medicinal market in
2016 [12].
Until 2018, there were no rules in place at the state or local levels in California for testing
contaminants, even for products legally marketed as medicinal cannabis [5,13]. A minority of
medicinal cannabis retailers in the pre-2018 state-unregulated market was routinely testing
and labeling cannabis for THC potency, but few were voluntarily testing for contaminants.
Informal evidence suggests that pesticide residues were common in cannabis products in the
pre-regulated market. For example, in 2017 an investigation reported that 93% of 44 samples
collected from 15 cannabis retailers in California had pesticide residues [14].
California’s cannabis testing standards
The mandatory testing framework introduced under MAUCRSA is summarized in Table 1,
where we briefly describe the tests for specific types of batches and the standards for passing
each test. Dried cannabis flower (or “harvest batches”) and cannabis products (or “manufac-
tured batches”) must be tested for concentrations of cannabinoids and various contaminants
in order to enter the legal market. Some tests (for cannabinoids, presence of foreign material,
pesticides, heavy metals, mycotoxins, microbial impurities and terpenoids) apply to all batches,
while some others (moisture content, residual solvents, processing chemicals) only apply to
some forms of cannabis. Heavy metals tests (for traces of lead, cadmium, arsenic, and mer-
cury) were not mandatory until December 2018.
Table 2 shows the list of contaminants with their maximum tolerance levels allowed in Cali-
fornia. Tolerance levels are generally lower for products that are inhaled than for products that
are eaten or applied topically. For 21 pesticides, the maximum residual level is zero, meaning
that no trace of those residues may legally be detected in a sample of cannabis.
MAUCRSA requires that all batches of cannabis flowers and products must be sampled and
tested by licensed laboratories before being delivered to retailers. Distributors are responsible
for testing (although cultivators, manufacturers, and retailers may also hold distributor
licenses). Fig 1 shows the flow of cannabis testing in California. The weight of a harvest batch
cannot exceed 50 pounds; larger batches must be broken down into 50-pound sub-batches for
testing. The sample size must be bigger than 0.35% of its weight. A processed batch cannot sur-
pass 150,000 units.
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After testing each batch, laboratories must file a certificate of analysis (COA) indicating the
results to distributors and to the BCC. If a sample fails any test, the batch that it represents can-
not be delivered to dispensaries for marketing. Instead, it can be remediated or reprocessed
(no more than twice) and fully re-tested again. If a batch fails a second re-testing after a second
remediation, or if a failed batch is not remediated, then the entire batch must be destroyed.
Analyzing the cannabis market, compared with other agricultural markets, presents a
unique challenge to researchers because of the rapidly changing legal environment, the lack of
historical data or scientific studies, the lack of government tax data, and the cash nature of the
business. Testing prices are not publicly advertised by licensed laboratories. Quotes are known
to vary depending on the number of samples, the frequency of testing, the type of contract
between the distributor and the laboratory, among others. Bulk pricing is common and is
negotiated on a case-by-case basis.
We approximate the costs of testing by collecting detailed data on the testing process and
constructing in-depth estimates of the capital, fixed, and variable costs of running a licensed
testing laboratory in California. We use these results in a set of simulations that estimate the
costs per pound generated by cannabis testing under the California regulations in place as of
mid-2019. We make some market assumptions based on the most reliable industry data avail-
able as of this writing in order to estimate the current cost per pound of testing compliance.
Table 1. Summary of mandatory testing per batch type and criterion used to pass tests.
Type of Test Description Batch Tested Criterion Required to Pass Test
Cannabinoids1 Measure concentration of THC, THCA, CBD,
CBDA, CBG, and CBN
All �10mg of THC per serving of edibles.�100mg of THC per package
of medical use only products.�500mg of THC per package of
medical use only orally dissolving products.�1000mg of THC per
package of topical products.�2000mg of THC per package of
medical use only topical products.
Foreign material2 Determine presence of foreign material (hair,
insects, feces, packaging contaminants, and
manufacturing waste)
All � 1/4 of sample area covered by sand, soil, cinders, dirt, mold, or any
imbedded foreign material.� 1 insect fragment, hair, or count
mammalian excreta per 3g
Pesticide3 Absence of 21 and limited presence of 45 pesticide
residues
All Levels of specific contaminants below action levels (see Table 2)
Heavy metals4 Limited presence of four heavy metals All Levels of specific contaminants below action levels (see Table 2)
Mycotoxins4 Screening of Aflatoxin B1, B2, G1, and G2, and
Ochratoxin A
All Aflatoxin B1, B2, G1, and G2, and Ochratoxin A < 20 μg/g
Microbial impurities1 Screening of Shiga toxin -Escherichia coli,
Salmonella spp., and pathogenic Aspergillus
species
All † Shiga toxin and Salmonella spp., and Aspergillus species (A.
fumigatus, flavus, niger, and terreus), undetected in 1g
Moisture content1 and
water activity4
Measure of moisture content, and water activity
(Aw) according with type of product
Flowers, solid
edible products
Aw� 0.65 for dried flowers or� 0.85 for solid and semi-solid edible
products. Lab must report moisture content as a percentage.
Solvent and processing
chemical3
Absence of six and limited presence of 14 solvent
and processing chemical residues
Cannabis
products or pre-
rolls
Levels of specific contaminants below action levels (see Table 2)
Terpenoids4 Determination if sample conforms to the labeled
content of terpenoids
All labeled
products
The laboratory must report the result of the terpenoid testing as a
percentage in mg/g or mg/mL depending on the type of product.
Source: MAUCRSA and California regulations (November 2018)
† Screening of Aspergillus species only in inhalable cannabis or inhalable cannabis products.
Phase-In of Testing Regime:
1 All cannabis harvested or manufactured on or after January 1, 2018, must have been tested for this item.
2 In addition to the analytical tests required in 1, all cannabis harvested or manufactured on or after July 1, 2018, must have been tested for this item.
3 Category I of pesticides and II of and solvents-and-processing chemicals must have been tested for cannabis harvested or manufactured on or after January 1, 2018.
Category II of pesticides and I of solvents-and-processing chemicals must have been tested for cannabis harvested or manufactured on or after July 1, 2018.
4 In addition to the analytical tests required in 1, 3, and 3, all cannabis harvested or manufactured on or after December 31, 2018, must have been tested for this item.
https://doi.org/10.1371/journal.pone.0232041.t001
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Table 2. Tolerance levels for pesticide residues, heavy metals, residual solvents, and processing chemicals in can-
nabis and cannabis products in California.
Type of Contaminant Tolerance Level (μg/
g)2
Pesticide residues
Aldicarb, Carbofuran, Chlordane, Chlorfenapyr, Chlorpyrifos, Coumaphos, Daminozide,
DDVP (Dichlorvos), Dimethoate, Ethoprop(hos), Etofenprox, Fenoxycarb, Fipronil, Imazalil,
Methiocarb, Methyl parathion, Mevinphos, Paclobutrazol, Propoxur, Spiroxamine,
Thiacloprid1
0 (I), 0 (O)
Acephate, Acetamiprid, Bifenazate 0.1 (I), 5 (O)
Abamectin 0.1 (I), 0.3 (O)
Acequinocyl 0.1 (I), 4 (O)
Azoxystrobin 0.1 (I), 40 (O)
Bifenthrin 3 (I), 0.5 (O)
Boscalid 0.1 (I), 10 (O)
Captan 0.7 (I), 5 (O)
Carbaryl 0.5 (I), 0.5 (O)
Chlorantraniliprole 10 (I), 40 (O)
Clofentezine 0.1 (I), 0.5 (O)
Cyfluthrin 2 (I), 1 (O)
Cypermethrin 1 (I), 1 (O)
Diazinon 0.1 (I), 0.2 (O)
Dimethomorph 2 (I), 20 (O)
Etoxazole 0.1 (I), 1.5 (O)
Fenhexamid 0.1 (I), 10 (O)
Fenpyroximate, Flonicamid, Hexythiazox 0.1 (I), 2 (O)
Fludioxonil 0.1 (I), 30 (O)
Imidacloprid 5 (I), 3 (O)
Kresoxim-methyl 0.1 (I), 1 (O)
Malathion 0.5 (I), 5 (O)
Metalaxyl 2 (I), 15 (O)
Methomyl 1 (I), 0.1 (O)
Myclobutanil 0.1 (I), 9 (O)
Naled 0.1 (I), 0.5 (O)
Oxamyl 0.5 (I), 0.2 (O)
Pentachloronitrobenzene 0.1 (I), 0.2 (O)
Permethrin 0.5 (I), 20 (O)
Phosmet 0.1 (I), 0.2 (O)
Piperonylbutoxide 3 (I), 8 (O)
Prallethrin 0.1 (I), 0.4 (O)
Propiconazole 0.1 (I), 20 (O)
Pyrethrins 0.5 (I), 1 (O)
Pyridaben, Spinetoram, Spinosad 0.1 (I), 3 (O)
Spiromesifen 0.1 (I), 12 (O)
Spirotetramat 0.1 (I), 13 (O)
Tebuconazole 0.1 (I), 2 (O)
Thiamethoxam 5 (I), 4.5 (O)
Trifloxystrobin 0.1 (I), 30 (O)
Heavy metals (not mandatory until 12/31/2018)
Cadmium 0.2 (I), 0.5 (O)
(Continued)
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Materials and methods
We construct a simulation model using R software [15] to assess the cost structure of cannabis
testing in California under the current regulatory framework. We base our simulations on the
number of testing labs (n = 49) and distributors (n = 1,210) that had been granted temporary
licenses by the BCC as of April 2019. The number of labs and distributors in California will
fluctuate as the industry continues to develop.
To estimate costs incurred by labs, we first construct estimates of fixed and variable costs
for labs based on their testing capacities. We calculate the cost of testing a sample of dried can-
nabis flower considering the lab scale and the distances between labs and distributors. Based
on meetings with representatives of California testing labs, we assume that 70%, 20%, and 10%
of the labs are distributed into small, medium, and large size categories. We assume that the
testing industry is like many others in that many small firms (that have relatively high costs)
supply relatively little of the output. We run 1,000 simulations to estimate the cost of sampling
and testing for a sample of a typical batch of dried flowers from each of the 49 labs, assuming
that costs, working hours, testing capacities, etc., may vary from lab to lab.
Next, we use the weighted average of testing cost per sample to estimate cost per pound.
We express total testing cost in dollars per pound of legal cannabis that reaches the market,
after incorporating costs of remediating and re-testing failed batches and losses from batches
of cannabis that cannot be remediated and must be destroyed.
Data
We used the list published by the BCC [16] to identify actively licensed testing labs and
requested, to managers or representatives, a personal or phone-call interview based on a set of
questions that we used as a guideline (S1 Appendix). We interviewed one-fourth of the
Table 2. (Continued)
Type of Contaminant Tolerance Level (μg/
g)2
Lead 0.5 (I), 0.5 (O)
Arsenic 0.2 (I), 1.5 (O)
Mercury 0.1 (I), 3 (O)
Residual solvent and processing chemicals
1,2-Dichloroethane, Benzene, Chloroform, Ethylene oxide, Methylene chloride,
Trichloroethylene1
1 (I or O)
Acetone 5000 (I or O)
Acetonitrile 410 (I or O)
Butane, Ethanol, Ethyl acetate, Ethyl ether, Heptane 5000 (I or O)
Hexane 290 (I or O)
Isopropyl alcohol 5000 (I or O)
Methanol 3000 (I or O)
Pentane, Propane 5000 (I or O)
Toluene 890 (I or O)
Total xylenes (ortho-, meta-, para-) 2170 (I or O)
Source: MAUCRSA and California regulations (November, 2018)
1 These pesticides or residual solvents are categorized as I, while the rest of pesticides or residual solvents are
categorized as II.
2 I denotes the tolerance levels for inhalable cannabis, and O the tolerance levels for any other type of cannabis.
https://doi.org/10.1371/journal.pone.0232041.t002
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operating or prospective licensed testing labs listed by the BCC. We gathered data on market
prices for testing equipment, supplies and chemical reagents consumed by equipment, equip-
ment running capacities, and other cannabis testing inputs needed to build a compliant testing
laboratory in California. Likewise, we collected financial, managerial, and logistics data. To
complement licensed testing lab data, we also drew on personal interviews, phone calls, and
email exchanges with sales representatives of three large equipment suppliers. Table 3 summa-
rizes capital costs, other one-time expenses, and annual operational and maintenance costs
used in our calculations. We report average cost and standard deviation for each estimate.
We assume that medium-sized and large labs receive discounted prices on equipment,
given the larger scale of their purchases. Based on information provided by equipment suppli-
ers, we expect these discounts to be between 1.5% and 2.5%. Different-sized labs have different
capacities based on their scale. We assume that larger labs have made larger capital invest-
ments and are better able to optimize processes when supplying a larger volume of testing (for
instance, by minimizing lab downtime through redundancy in equipment). On the other
hand, small testing labs require less equipment and less capital investment, and operate with
low annual costs, but their testing capacities are also low. Table 4 summarizes our estimates of
running time for tests, the main consumables used by testing machines, and the expected cost
of running a specific test per sample. In addition, we include a range of $80 to $120 per sample
to cover general material and labor apparel (e.g., tubes, glassware, goggles, masks, gloves, etc.)
used while preparing and processing samples.
Calculating laboratory cost per sample of cannabis
We break down the laboratory cost per successfully tested sample (Ci) of each lab (i = 1,. . ., 49)
into two major components: the per-sample cost of testing itself (Ai), and the per-sample cost
of collecting, handling and transporting samples from distributors to labs (Si), thus Ci = Ai+Si.
Fig 1. California’s cannabis testing process.
https://doi.org/10.1371/journal.pone.0232041.g001
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First, we consider the cost of testing per sample, which is equal to the annual total cost of
running a testing lab (ACi), plus the associated total return to risk and profit for the lab,
divided by Qi, the number of samples successfully tested per year. Qi is defined and explained
below. The return to risk and profit is calculated as rate of return π (e.g. 15%), multiplied by
the amount of invested capital (Fi).
Ai ¼
ACi þ Fip
Qi
ð1Þ
Notice that invested capital enters per-unit costs in two places: one is a separate term for
the rate of return π times the amount of invested Fi, and the other is a component of the cost
of operating the lab.
The annual cost of running a testing lab (ACi) includes the annualized cost of capital
invested (Fi) (equipment and other one-time expenses, including startup and sampling equip-
ment, and implementation of ISO), annual operational and maintenance costs (OMi), and
annual labor costs (Li), thus ACi = Fi+OMi+Li (see Tables 3 and 4 for detailed costs).
Table 3. Average expected costs of implementing a licensed cannabis testing laboratory in California.
Item Range1 Cost2
Cannabis testing equipment costs
High-performance liquid chromatography (HPLC) 1–2 $85,195 ($20,261)
Inductively coupled plasma mass spectrometry (ICP-MS) 1–2 $259,874 ($11,847)
Liquid chromatography-mass spectrometry (LCMS) 1–3 $502,807 ($50,255)
Gas chromatography-mass spectrometry (GCMS) 1–4 $135,258 ($8,533)
Real-time polymerase chain reaction test (PCR) 1–2 $50,071 ($4,995)
Moisture balance (MB) 1–2 $9,994 ($1,019)
Other one-time costs
Start-up and support equipment 2–4 $237,284 ($50,176)
Sampling equipment and vehicles 1–5 $19,927 ($4,011)
ISO implementation IQ&OQ protocols 1–2 $249,257 ($24,356)
Annual costs of operations and maintenance
Compliance with ISO/IEC-17025 standards $24,990 ($577)
Maintenance3 $347,785 ($150,166)
Real estate $317,549 ($124,284)
Utilities $72,535 ($29,579)
Sales, general & administrative costs $89,335 ($32,847)
Lab fees $51,667 ($28,968)
Annual salary and benefits
Director 1–1 $133,274 ($8,973)
Manager 0–3 $94,867 ($6,963)
Analyst 2–5 $65,011 ($6,470)
Technician 2–5 $45,654 ($3,784)
Sampler 1–5 $45,993 ($4,038)
Staff 2–4 $44,000($3,566)
Source: Equipment suppliers and licensed testing laboratories.
1 Range (minimum and maximum) of equipment and labor used depending on the size of each lab (small, medium,
or large).
2 Values represent the average cost, with standard deviations in parentheses.
3 Maintenance cost depends on the number of equipment of each lab.
https://doi.org/10.1371/journal.pone.0232041.t003
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We calculate the annualized flow of capital invested (Fi) based on a formula typically used
in budgeting studies (Eq 2):
Fi ¼
rK
1   ð1þ rÞ  h
; ð2Þ
where Ki denotes the total cost of capital and one-time expenses, r denotes an assumed annual
discount rate that reflects the combined effects of depreciation and interest (we use r = 7.5%),
and h denotes the number of years to the investment horizon (we use h = 10 years).
The number of samples successfully tested per year (Qi), OMi, and Li all depend on the size
of each lab, e.g. the number of pieces of each type of testing equipment, number of employees,
working hours per employee, and so on. We assume that small-scale labs operate with the min-
imum necessary investment in testing equipment, maintenance, staff, and operating hours,
while large-scale labs operate with much higher investment in testing equipment, mainte-
nance, staff, and operating hours.
To estimate Qi for each lab, we make four sets of assumptions about each lab’s operational
efficiency. Our efficiency assumptions depend on the lab’s size. First, we estimate a lab’s poten-
tial single-day testing capacity qi, which is the maximum number of samples per day that could
theoretically be tested (successfully or unsuccessfully) by a lab’s machinery if it were operating
continuously. We use the testing time per sample (TSk) of each piece of equipment (see
Table 4) and the total testing operational hours per day of each lab (TTi) to calculate qi.
Because large-scale labs hire and manage more workers, we assume that they conduct testing
for 14 hours per day (with a standard deviation of 0.06 hours); while small and medium-scale
labs conduct testing for about 8 hours per day (with a standard deviation of 0.06 hours).
We assume that multiple tests can be run from a single sample, some machines can run
simultaneously, and some machines run more than one type of test (see Table 4). Based on
these assumptions, we calculate the total number of samples tested per day per one (or more)
machines of the same type (nk), such that qnki ¼
nk
TSk
TTi, where n = 1,. . ., n (see Table 3), and
k = 1, . . ., 6 (see Table 4). We then constrain the total number of samples tested per day by
using the minimum number of samples tested per one (or more) machines of the same type,
such that qi ¼ minfqn1i ; . . . ; q
n6
i g.
Table 4. Main consumables used by each cannabis testing lab machine, estimated testing time and cost per sample.
Machine Type of Analysis Testing
Time
Consumables Cost per
test1
High-performance liquid chromatography
(HPLC)
Cannabinoids 10 min Water grade, acetonitrile, chemicals used for extraction and
cleanup
$1.57
($0.34)
Inductively coupled plasma mass
spectrometry (ICPMS)
Heavy metals 5 min Argon gas, chemicals used for extraction and cleanup $1.52
($0.29)
Liquid chromatography-mass spectrometry
(LCMS)
Residual pesticides and
mycotoxins
12 min Liquid Nitrogen, water grade, methanol, chemicals used for
extraction and cleanup
$8.82
($1.05)
Gas chromatography-mass spectrometry
(GCMS)
Residual pesticides and
solvents
20 min Helium gas, chemicals used for extraction and cleanup $2.52
($0.31)
Real-time polymerase chain reaction test
(PCR)
Microbial 4 min Chemicals used for extraction and cleanup $7.49
($0.87)
Moisture balance (MB) Moisture 10 min Chemicals used for extraction and cleanup $1.25
($0.15)
Source: Equipment supplier companies and licensed testing laboratories.
1 Values represent the average cost, with standard deviations in parentheses.
https://doi.org/10.1371/journal.pone.0232041.t004
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Second, we assume that during each operating day, a lab runs at some percent operational
efficiency Ri of its maximum daily testing capacity qi. Efficiency percent Ri is defined as the
ratio of actual tests per day performed by a lab to total possible tests per day qi; thus (qi � Ri)
gives the number of actual tests per day performed by a lab. We assume that the operational
efficiency ratio Ri is a function of equipment redundancy, maintenance-related downtime, effi-
cient scheduling with customers, and other operational factors, which together are propor-
tional to lab size. After many interviews with lab operators, we assume that Ri is about 55%
(with a standard deviation of 2.9%) for small labs, 70% (with a standard deviation of 2.9%) for
medium labs, and 80% (with a standard deviation of 2.9%) for large-scale labs.
Third, we assume that labs, even when fully operational, will perform some unsuccessful
tests (e.g., where machines fail, errors are made by lab technicians, or results are ambiguous,
such that the lab is unable to issue a certificate of analysis without re-testing the sample at its
own expense). We assume that small and medium-scale labs, because they have less experience
and are likely to have less well-trained staff, have higher rates of unsuccessful tests than large-
scale labs. We denote the ratio of successful tests to all tests as Ei, and we assume that this suc-
cessful testing ratio Ei is about 80% (with a standard deviation of 1.7%) in small- and medium-
scale labs, and about 96% (with a standard deviation of 1%) in large-scale labs.
Fourth, we assume that small-scale labs operate fewer days per year than large-scale labs. In
Eq (3), we denote the lab’s operational days per year as Di. Based on information provided by
representatives of testing labs, we assume that Di is 240–260 days for small-scale labs, 250–270
days for medium-scale labs, and 280–300 days for large-scale labs.
The total number of samples successfully tested per year (Qi) is expressed in Eq (3) as a
function of the four sets of operational assumptions described above:
Qi ¼ qi � Ri � Ei � Di ð3Þ
Next, we must estimate sampling cost (Si), which includes transportation, labor, equipment,
and material costs. We use the zip codes of active licensed testing labs (denoted by i) and dis-
tributors (denoted by j) published by the BCC [16] to estimate the distance from labs to dis-
tributors (dij). Using the R software [15] and the zip codes of active licensed testing labs and
distributors [16], we generate a map that shows the geographical location of licensed labs and
distributors in mid-2019 (Fig 2). We have no information about which labs served which dis-
tributors. However, we expect that labs are better able to compete for nearby distributors
because they would have lower transportation time and cost and may be more likely to have
closer business relationships.
In order to estimate average transport costs from distributors to labs, we randomly assigned
distributors located within a 160 mi radius to each lab. Based on 2019 data, this was the longest
travel distance from a distributor to the nearest lab. This travel distance radius ensures that
each distributor in the sample is covered by at least one laboratory.
Based on the annual number of samples that we estimate each lab is able to test (Qi), we esti-
mate the share of total testing done by small labs, medium labs, and large labs. We then esti-
mate the number of distributors per lab. In each of our 1,000 simulations, 70% of the 49
licensees (34 labs) with specific locations were randomly chosen to represent small-scale labs,
20% (10 labs) were randomly chosen to represent medium-scale labs, and 10% (5 labs) were
randomly chosen to represent large-scale labs.
PLOS ONE Costs of testing cannabis in California
PLOS ONE | https://doi.org/10.1371/journal.pone.0232041 April 23, 2020 10 / 20
Eq 4 shows our calculation of sampling cost as the average cost of sampling from each dis-
tributor supplied by sampling and testing from an ith lab.
Si ¼
1
n
Xn
j¼1
0:535 � dij � TDij
Qij
þ
Xn
j¼1
4:5þ
dij
sp � Ls � TDij
Qij
þ
Xn
j¼1
50 � TDij
Qij
 !
ð4Þ
The first term of the right hand side of Eq 4 shows transportation cost. The term dij denotes
the distance, back and forth, from an ith lab to a jth distributor, and TDij the number of trips,
per-sampler, needed to collect the total samples (Qij) from a particular distributor within a
year. We use the cost of transportation as $0.58 per mile, the Federal reimbursement rate per
mile for California. The second term of the right hand side of Eq 4 shows the labor cost of sam-
pling. We include the time spent sampling and traveling back and forth to distributors. We use
$18 per hour as the labor opportunity cost of sampling (Ls), and used 15 minutes as the average
time used to retrieve one sample from a batch. We expect that a sampling employee will collect
at least 10 samples from a distributor in one visit (i.e.,
0:25hr�Qij
Qij
� 18=hr ¼ 4:5). We used a range
of speed (sp) between 50 and 60 miles per hour to calculate the time spent traveling (i.e., dijsp).
The third term of the right-hand side of Eq 4 shows the material cost of sampling. Based on
Fig 2. Locations of licensed testing labs and distributors in California. (Source: Bureau of Cannabis Control, April
of 2019).
https://doi.org/10.1371/journal.pone.0232041.g002
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information provided by testing labs, we assume a $50 cost of materials per visit, including dis-
posables such as gloves, masks, etc.
Calculating cost per pound of cannabis marketed
Our estimates of cost per pound of cannabis that reaches the market (m) includes laboratory
cost (c), the value of lost inventory (v), and the cost of remediation of failed batches (z): m = c
+v+z. Laboratory cost per pound of marketed cannabis (c) is expressed by Eq 5:
c ¼
�C
B
þ �G
� �
� TP; ð5Þ
where �C is a weighted average of the lab cost per sample using the share of annual testing capa-
bilities of each lab, B is the batch size or number of pounds of a batch of cannabis flower from
which a sample is taken for analysis, �G is the weighted average of per-pound cost of security
compliance, and TP is the ratio of the number of pounds tested per pound that passes testing.
We use a range of values less than or equal to 50 pounds for B, as MAUCRSA sets a maxi-
mum batch size of 50 pounds of cannabis flower (or 150,000 units for processed cannabis
products) [1]. We use a weighted average of security compliance cost of $3.92 per pound
($4.88 for G in small labs, $4.06 in medium labs, and $3.25 in large-scale labs). These costs
include video surveillance and archival, disposal and quarantine, and other compliance esti-
mated elsewhere [10]. Eq 6 shows the calculation of TP:
TP ¼
1þ pre:test%þ fail% � re:test%
1   ðfail%   fail% � re:test% � fail:re:test%Þ
ð6Þ
The numerator of Eq 6 expresses total pounds tested (including pre-tested and rejected
pounds), and the denominator expresses total pounds that pass testing. Based on our best esti-
mates after interviewing testing labs and gathering data from other states, we set the pre-test
share at 25%, the re-tested share of failed samples at 50%, and the failure rate of re-tested sam-
ples at 50%.
We use a range of failure rates from 0% to 8% based on the ranges of cannabis testing failure
rates that have been observed in California in 2018 and 2019 [17], and by comparing cannabis
tolerance levels with data on pesticide residue detection in other crops of California [18]. Can-
nabis and cannabis products are offered to be consumed via edibles or inhalable. Here we treat
cannabis like any other crop in California.
Table 5 shows the percent of California food products with any detection of pesticide resi-
dues and above the U.S. Environmental Protection Agency (EPA) tolerance levels, from 2015
to 2017. We estimate that about 13% of over 7,000 samples would have been above the inhal-
able cannabis product tolerance limits, whereas about 4% would have exceeded even the less
stringent tolerance levels established for other (non-inhalable) cannabis products (Table 5).
The value of lost inventory (v) includes the cost of the cannabis used up in the testing proce-
dures (�p � s) and the cost of cannabis that must be destroyed when it has failed testing twice
(�p � d). We use a wholesale price of cannabis flower of $1,360 per pound as a weighted average
(�p) from outdoor, greenhouse, and indoor grow types [10]. Eq 7 expresses the value lost inven-
tory per pound of cannabis that passes testing.
v ¼
�pðsþ dÞ
1   ðfail%   fail% � re:test% � fail:re:test%Þ
ð7Þ
To calculate the amount of cannabis that must be removed from inventory for testing (s),
we include a fraction (0.35%) of the batch size (B) that is removed for testing, and a fraction
PLOS ONE Costs of testing cannabis in California
PLOS ONE | https://doi.org/10.1371/journal.pone.0232041 April 23, 2020 12 / 20
that is retested after failing the first round of testing, and a fraction that is pre-tested (Eq 8).
s ¼ ð0:0035Bþ 0:0035B � fail% � re:test%þ 0:0035B � pre:test%Þ=B ð8Þ
We calculate the amount of cannabis that is destroyed after remediation (d) by using a frac-
tion of cannabis that fails (between 0% and 8%) minus the share of cannabis that passes the
second test (Eq 9).
d ¼ fail%   fail% � re:test% � fail:re:test% ð9Þ
As for the value of lost inventory, Eq 10 shows how we estimate the remediation cost of
failed batches at per pound of cannabis that passes testing (z). Based on our interviews with
operators, we assume that the cost of remediation P (processing batches that did not pass the
first round of testing) is $20 per pound.
z ¼
P � fail% � fail:re:test%
1   ðfail%   fail% � re:test% � fail:re:test%Þ
ð10Þ
Results of simulations
Laboratory cost per sample of cannabis
The minimum capital investment in testing equipment needed to satisfy regulations is sub-
stantial. We estimate that in small labs (n = 34), capital investment in equipment is about $1.1
million; in the medium-sized labs (n = 10), capital investment in equipment is about $1.8 mil-
lion; and in large-scale labs (n = 5), capital investment in equipment is about $2.8 million.
These capital costs, amortized over a 10-year time span with a 7.5% rate of depreciation and
interest, represent less than 15% of total annual expenses. Annual costs of operating range
from $1.4 to $2.2 million for small labs, $2.7 to $3.7 million for medium-sized labs, and $6.2 to
$8.1 million for large labs. Consumables are the largest share of total annual costs in large-scale
labs, whereas labor is the largest share of costs in small-scale labs. In medium-scale labs, con-
sumables and labor have about equal shares of annual costs.
Different-sized labs differ in their capacity and efficiency. Large-scale labs test about four
times the amount of cannabis per hour than medium labs, and more than 10 times what small
labs test. The cost advantage of large testing labs comes from a more efficient use of inputs
such as lab space, equipment, and labor. Table 6 summarizes the average of estimated testing
capacities, annual costs, and testing cost per sample for each of the three lab size categories.
Cost of collection, handling and transport also vary by lab size. As of April 2018, the longest
distance between a lab and a distributor in California was about 156 miles. Fig 3 shows the cost
of collection, handling, and transportation (which we call the “sampling cost”) per sample for
distances between labs and distributors, of less than 156 miles. As expected, the longer the
Table 5. Percent of California food product samples indicating any detection of pesticide residues, above EPA tolerance levels, and percent above tolerance levels
for cannabis products (2015–2017).
Food product 2015 2016 2017 Total
With any detection of pesticide residues� 60.35% 60.06% 61.46% 60.52%
With pesticide residues above EPA tolerance levels� 0.32% 1.51% 0.45% 0.79%
Food that would have exceeded cannabis tolerance levels
Using criteria for inhalable cannabis products 12.86% 13.44% 12.79% 13.05%
Using criteria for other cannabis products 4.07% 3.62% 3.90% 3.86%
Source: California Department of Pesticide Regulation: Pesticide Residue Monitoring Program, and MAUCRSA and California regulations, 2018.
https://doi.org/10.1371/journal.pone.0232041.t005
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distance, the higher the sampling cost. Large labs have relatively low sampling costs even at
long distances. The highest possible sampling cost we assume for small labs is about $35 per
sample if the distributor is located 156 miles away (Fig 3). On average, costs of collection, han-
dling, and transportation represents a small share (about 2.5%) of total lab costs per sample.
Fig 4 shows the distribution of full testing cost per sample from 1,000 Monte Carlo simula-
tions assuming 49 labs. Variability of the cost per sample within small labs is high, with the
highest and lowest cost within that group differing by $463. The difference between the highest
and lowest costs in large labs is $88, with a lowest cost per sample of about $273. The average
full cost per sample tested is about $313 for large labs, $537 for medium labs, and about $778
for small labs (see Table 6).
Large cost differences per test and per batch document the large-scale economies and dif-
ferences in operational efficiencies across labs of difference sizes. The aggregate amount of
cannabis flowing through licensed labs in 2019 remains relatively small relative to the antici-
pated amounts expected in the future. That means labs that may anticipate growth, operate
well below capacity. Substantial scale economies suggest that, as the market settles, the smallest
labs must either expand to use their capital investment more fully, leave the industry, or pro-
vide some specialized services to distributors that are not accounted for in the analysis pre-
sented here. Simply put, the average cost differences shown in Table 6 or the simulated ranges
displayed in Fig 4 should not be understood as a long run equilibrium in the cannabis testing
laboratory industry.
Testing cost per pound of cannabis marketed
Based on the shares developed based on current information, a few large labs are likely to sup-
ply almost half the testing services for cannabis sold through licensed retailers in California,
while medium labs will test about 24% of cannabis and small labs about 30% of cannabis.
Using these shares and the cost information documented, the weighted average of testing cost
from our simulations is about $504 per sample.
Table 6. Testing capacity, itemized annual costs, and testing cost per sample by laboratory scale.
Scale category Large (n = 5) Medium (n = 10) Small (n = 34)
Mean number of effective samples analyzed year 23,312 5,895 2,173
Annual costs (Thousands)
Capital investment, interest plus depreciation1 $562.02 $378.87 $235.38
Operating and maintenance costs
Equipment maintenance and acquisition and maintenance of ISO/IEC-17025 $615.76 $422.16 $233.07
Rent and basic utilities $484.95 $332.71 $228.41
Sales, general and administrative costs $129.96 $88.01 $49.99
License fees $90.00 $45.00 $20.00
Labor $1,721.89 $895.77 $518.68
Consumable costs $3,430.88 $866.90 $319.35
Return to risk and profit (15%) $84.30 $56.83 $35.31
Total costs $7,119.76 $3,086.25 $1,640.18
Costs per sample
Average cost per sample of within lab testing $306 $525 $757
Cost of sampling (collection, transport and handling) $8 $13 $21
Average cost per sample of testing $313 $537 $778
Values represent averages from 1,000 Monte Carlo simulations using distributions presented in Tables 3 and 4. Totals may not reflect sums of rows due to rounding.
https://doi.org/10.1371/journal.pone.0232041.t006
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In 2018, the first year of mandatory testing enforcement, according to official data pub-
lished by the California Bureau of Cannabis Control and posted publicly on its website, failure
rates in California averaged about 5.6% (not including failures due to “label claims,” i.e. incor-
rect cannabinoid content reported on the label, which can be corrected at little cost by re-label-
ing without remediation). Failure rates for the first seven months of 2019, the second year of
the testing regime, have averaged 4.1% [17]. We assume a 4% failure rate for the current mar-
ket in California.
By comparison, in Washington State, in 2017, the second year after the testing began, 8% of
the total samples failed one or more tests [19]. The Colorado Marijuana Enforcement Division
reported that during the first six months of 2018, 8.9% of batches of adult-use cannabis failed
testing, with infused edibles and microbial tests for flower accounting for the most failures [8].
Batch size significantly affects the per-pound testing cost of cannabis marketed, especially
when batch size is smaller than 10 pounds. Fig 5 shows the costs of one pound of cannabis
marketed coming from different sizes of batch flowers using 0%, 4%, and 8% rejection rates.
As rejection rates increase, the differences between the costs per pound of testing different
batch sizes decreases. For example, given a 0% rejection rate, the cost of testing per pound of
cannabis marketed from a one-pound batch is about 27 times higher than the cost of a
48-pound batch; on the other hand, given an 8% rejection rate, the cost of testing per pound of
cannabis marketed from a one-pound batch size is only seven times higher than the cost from
a 48-pound batch size.
Fig 3. Sampling cost (collection, handling, and transportation) at different distances between a lab and a distributor.
https://doi.org/10.1371/journal.pone.0232041.g003
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Table 7 shows costs per pound of cannabis testing itemized into laboratory cost, the value
of lost inventory, and the cost of remediating failed batches, given different rejection rates and
batch sizes. For small batch sizes, laboratory costs are a higher share of total testing costs than
they are for large batch sizes. For a one-pound batch size, the total cost of testing of a pound of
cannabis that reaches the market is about $641 when the expected rejection rate is equal to
zero. The cost increases to $714 if the expected rejection rate is equivalent to 4%, and to $791 if
the expected rejection rate is 8% (Table 7).
The share of laboratory cost from total cost decreases as the rejection rate increases and the
value of lost inventory therefore increases. Under an 8% expected rejection rate, the share of
lost inventory is half of the total cost for eight-pound batches (Table 7).
Discussion
In this paper, we use a simulation model to estimate the costs per pound of mandatory canna-
bis testing in California. To do this, we make assumptions about the cost structure and esti-
mated the testing capabilities of labs in three different size categories, based on information
collected from market participants across the supply chain. For each lab, we estimate testing
cost per sample and its share, based on testing capacity, of California’s overall testing supply.
We then estimate a weighted average of the cost per sample and translate that value into the
cost per pound of cannabis that reaches the market.
Fig 4. Testing cost per sample from a batch of cannabis flower (Ci) estimated for small, medium, and large labs using 1,000 Monte Carlo simulations.
https://doi.org/10.1371/journal.pone.0232041.g004
PLOS ONE Costs of testing cannabis in California
PLOS ONE | https://doi.org/10.1371/journal.pone.0232041 April 23, 2020 16 / 20
We use data-based assumptions about expected rejection rates in the first and second
round of testing, pre-testing, and the remediation or processing of samples that fail testing.
Our simulations rely on information collected from several sources, including direct informa-
tion from testing labs in California, price quotes from companies that supply testing equip-
ment, interviews with cannabis testing experts, data on testing outcomes for cannabis and
other agricultural products from California and other states, data on pesticide detection in Cal-
ifornia crops, and data on average wholesale cannabis batch sizes.
Costs needed to start a testing lab that meets California regulations depend on the scale of
the lab. As lab scale rises, testing capacity rises faster than do input costs, so average costs fall
with scale. We find that a large lab has four times the total costs of a small lab but 10 times the
testing capacity, in part because large labs are able to use their resources (equipment, lab space,
labor) more efficiently.
Testing cost per pound of cannabis marketed is particularly sensitive to batch size, espe-
cially for batch sizes under 10 pounds. Testing labs report that batch size varies widely. The
maximum batch size allowed in California is 50 pounds, but many batches are smaller than 15
pounds. We assume an eight-pound average batch size in the 2019 California market, but we
expect that the average batch size will increase in the future as cultivators become larger and
more efficient and take advantage of the opportunity to save on testing costs (and other costs
that vary nonlinearly with batch size).
Fig 5. Testing costs per pound of cannabis marketed at different batch sizes and rejection rates.
https://doi.org/10.1371/journal.pone.0232041.g005
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Testing itself is costly, but losses inflicted by destroying cannabis that fails testing is a major
component of overall costs. Low or zero tolerance levels for pesticide residues are the most
demanding requirement, and result in the greatest share of safety compliance testing failures
[17]. Cannabis standards are very tight compared to those for food products in California. A
significant share of tested samples from California crops have pesticide residues that would be
over the tolerance levels established for California cannabis (see Table 5). Some foods that
meet pesticide tolerance established by California EPA may be combined with dried cannabis
flowers to generate processed cannabis products (such as baked goods, for example). Pesticide
residues coming from the food inputs may generate detection levels of pesticide over the toler-
ance levels set by cannabis law and regulation, even if they are otherwise compliant as food
products. Cannabis testing regulation is strict compared to tobacco, another inhalable crop.
Tobacco has no pesticide tolerance limits because it is considered to be an inedible crop used
for recreational purposes [5]. Cannabis has multiple pathways of intake, such as edibles, inhal-
able, patches, etc., and also may be prescribed for people with a health condition, searching for
alternatives to traditional medicine.
Some labs report that when samples barely fail one test, they have a policy of re-testing that
sample to reduce the probability of false positives. Some labs have reported up to 10% in varia-
tion in test results from the same sample. Some labs indicate that about 25% of samples need
to be re-tested to be sure that results are accurate. Such concerns have been widely reported. In
July 2018, some producers voluntarily recalled cannabis products after receiving inconsistent
Table 7. Itemized costs per pound of cannabis that reaches the market at three rejection rates and different batch sizes.
Rejection Rate Batch Size Laboratory Cost Value of lost inventory Remediation Cost Per pound cost of cannabis marketed
0% 1 $634.71 $5.95 $0.00 $640.66
0% 2 $319.81 $5.95 $0.00 $325.76
0% 8 $83.63 $5.95 $0.00 $89.58
0% 24 $31.15 $5.95 $0.00 $37.10
0% 48 $18.03 $5.95 $0.00 $23.98
2% 1 $649.53 $26.80 $0.20 $676.53
2% 2 $327.28 $26.80 $0.20 $354.28
2% 8 $85.58 $26.80 $0.20 $112.59
2% 24 $31.88 $26.80 $0.20 $58.88
2% 48 $18.45 $26.80 $0.20 $45.45
4% 1 $664.81 $48.29 $0.41 $713.52
4% 2 $334.97 $48.29 $0.41 $383.68
4% 8 $87.60 $48.29 $0.41 $136.30
4% 24 $32.62 $48.29 $0.41 $81.33
4% 48 $18.88 $48.29 $0.41 $67.59
6% 1 $680.57 $70.46 $0.63 $751.66
6% 2 $342.92 $70.46 $0.63 $414.01
6% 8 $89.67 $70.46 $0.63 $160.77
6% 24 $33.40 $70.46 $0.63 $104.49
6% 48 $19.33 $70.46 $0.63 $90.42
8% 1 $696.83 $93.34 $0.85 $791.02
8% 2 $351.11 $93.34 $0.85 $445.30
8% 8 $91.82 $93.34 $0.85 $186.01
8% 24 $34.20 $93.34 $0.85 $128.39
8% 48 $19.79 $93.34 $0.85 $113.98
https://doi.org/10.1371/journal.pone.0232041.t007
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results of contaminant residues from different laboratories [20]; and some California labs have
also been sanctioned by the Bureau of Cannabis Control for failing state audits on pesticide
residue tests.
A major issue for legal, taxed and licensed cannabis market is competition with cannabis
marketed through untaxed and unlicensed segment. Higher testing costs translate into higher
prices in the licensed segment. Safety regulations and testing may improve the perceived safety
and quality of cannabis in the licensed segment, thus adding value for some consumers [21].
However, price-sensitive consumers move to the unlicensed segment when licensed cannabis
gets too expensive. A useful avenue for further research is to investigate cannabis testing regu-
lations and standards across states to assess implications for consumer and community wellbe-
ing and competition with unlicensed cannabis.
Compared with other agricultural and food industries, the licensed cannabis industry in
California has relatively little data. Banking is still done in cash, and sources of government
financial data are less available for cannabis than they are for other industries. As the licensed
cannabis segment develops, we expect that increased access to data on the market for testing
services, including on prices, quantities, and batch sizes. Data from tax authorities, the track-
and-trace system, and the licensing system will then help clarify the costs and implications of
mandatory cannabis testing.
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